Dexamethasone sodium phosphate
Download report
Favorite
Events Timeline
Commercial
Clinical
Drug
Target
Variants
Financial
Trends
Safety
Events Timeline
5D
1M
3M
6M
YTD
1Y
2Y
5Y
Max
Events
FDA approval date
EMA approval date
Patent expiration date
Study first post date
Last update post date
Start date
Primary completion date
Completion date
Results first post date
Mock data
Subscribe for the real data
Subscribe for the real data
Commercial
No data
Clinical
Clinical Trials
4745 clinical trials
View more details
Mock data
Subscribe for the real data
Subscribe for the real data
Indications Phases 4
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Multiple myeloma | D009101 | — | C90.0 | 327 | 609 | 222 | 19 | 66 | 1067 |
| Plasma cell neoplasms | D054219 | — | — | 184 | 360 | 119 | 13 | 49 | 621 |
| Postoperative pain | D010149 | — | G89.18 | 13 | 21 | 31 | 109 | 116 | 280 |
| Precursor cell lymphoblastic leukemia-lymphoma | D054198 | — | C91.0 | 65 | 132 | 65 | 20 | 18 | 258 |
| Lymphoma | D008223 | — | C85.9 | 44 | 162 | 43 | 11 | 13 | 246 |
| Vomiting | D014839 | — | R11.1 | 8 | 42 | 83 | 53 | 54 | 237 |
| Leukemia | D007938 | — | C95 | 49 | 112 | 52 | 14 | 13 | 207 |
| Nausea | D009325 | — | R11.0 | 5 | 34 | 59 | 45 | 37 | 178 |
| Neoplasms | D009369 | — | C80 | 54 | 66 | 28 | 9 | 17 | 152 |
| Postoperative nausea and vomiting | D020250 | EFO_0004888 | — | 3 | 18 | 19 | 53 | 49 | 137 |
Show 424 more
Indications Phases 3
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Amyloidosis | D000686 | EFO_1001875 | E85 | 14 | 40 | 13 | — | 8 | 67 |
| Plasmacytoma | D010954 | — | C90.3 | 5 | 34 | 14 | — | 2 | 54 |
| Immunoglobulin light-chain amyloidosis | D000075363 | — | — | 15 | 29 | 11 | — | 4 | 54 |
| Hodgkin disease | D006689 | — | C81 | 11 | 22 | 10 | — | 1 | 40 |
| Neoplasm metastasis | D009362 | EFO_0009708 | — | 17 | 19 | 6 | — | 3 | 39 |
| Precursor t-cell lymphoblastic leukemia-lymphoma | D054218 | — | — | 16 | 25 | 7 | — | — | 34 |
| Myeloid leukemia acute | D015470 | — | C92.0 | 16 | 10 | 5 | — | 1 | 26 |
| B-cell chronic lymphocytic leukemia | D015451 | — | C91.1 | 7 | 20 | 1 | — | 1 | 26 |
| Follicular lymphoma | D008224 | — | C82 | 7 | 16 | 4 | — | 2 | 26 |
| Brain neoplasms | D001932 | EFO_0003833 | C71 | 7 | 13 | 6 | — | 2 | 25 |
Show 252 more
Indications Phases 2
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| B-cell lymphoma marginal zone | D018442 | — | C88.4 | 3 | 11 | — | — | 1 | 13 |
| Cholangiocarcinoma | D018281 | — | C22.1 | 2 | 7 | — | — | 2 | 11 |
| Glioblastoma | D005909 | EFO_0000515 | — | 7 | 3 | — | — | 3 | 11 |
| Hyperaldosteronism | D006929 | — | E26 | 1 | 2 | — | — | 8 | 10 |
| Bcr-abl positive chronic myelogenous leukemia | D015464 | EFO_0000340 | — | 3 | 7 | — | — | — | 9 |
| Meningeal carcinomatosis | D055756 | EFO_1001012 | — | 3 | 6 | — | — | 2 | 9 |
| Cushing syndrome | D003480 | EFO_0003099 | E24 | — | 1 | — | — | 8 | 9 |
| Blast crisis | D001752 | — | — | 2 | 6 | — | — | 1 | 8 |
| Pituitary acth hypersecretion | D047748 | EFO_1001110 | E24.0 | — | 1 | — | — | 7 | 8 |
| Adrenal gland neoplasms | D000310 | EFO_0003850 | C74 | 1 | 1 | — | — | 6 | 8 |
Show 178 more
Indications Phases 1
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Hyperandrogenism | D017588 | — | — | 4 | — | — | — | 3 | 7 |
| Insulin resistance | D007333 | EFO_0002614 | E88.819 | 2 | — | — | — | 3 | 5 |
| Overweight | D050177 | — | E66.3 | 3 | — | — | — | 1 | 4 |
| Multiple sclerosis | D009103 | EFO_0003885 | G35 | 3 | — | — | — | 1 | 4 |
| Hairy cell leukemia | D007943 | — | C91.4 | 2 | — | — | — | 1 | 3 |
| Rheumatoid arthritis | D001172 | EFO_0000685 | M06.9 | 1 | — | — | — | 2 | 3 |
| Trigeminal neuralgia | D014277 | EFO_1001219 | G50.0 | 1 | — | — | — | 2 | 3 |
| Stroke | D020521 | EFO_0000712 | I63.9 | 1 | — | — | — | 2 | 3 |
| Female infertility | D007247 | EFO_0008560 | N97 | 1 | — | — | — | 2 | 3 |
| Alcoholism | D000437 | EFO_0003829 | F10.1 | 1 | — | — | — | 2 | 3 |
Show 70 more
Indications Without Phase
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Myopia | D009216 | EFO_0003927 | H52.1 | — | — | — | — | 5 | 5 |
| Rib fractures | D012253 | — | — | — | — | — | — | 4 | 4 |
| Morbid obesity | D009767 | EFO_0001074 | — | — | — | — | — | 4 | 4 |
| Sinusitis | D012852 | EFO_0007486 | J32 | — | — | — | — | 3 | 3 |
| Intraoperative complications | D007431 | — | — | — | — | — | — | 3 | 3 |
| Bilateral hearing loss | D006312 | — | — | — | — | — | — | 3 | 3 |
| Chalazion | D017043 | EFO_0007363 | H00.1 | — | — | — | — | 3 | 3 |
| Cryptorchidism | D003456 | EFO_0004562 | Q53.1 | — | — | — | — | 3 | 3 |
| Gallstones | D042882 | EFO_0004210 | — | — | — | — | — | 3 | 3 |
| Thoracic surgical procedures | D019616 | — | — | — | — | — | — | 3 | 3 |
Show 249 more
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
| Drug common name | Dexamethasone sodium phosphate |
| INN | — |
| Description | — |
| Classification | Unknown |
| Drug class | — |
| Image (chem structure or protein) |  |
| Structure (InChI/SMILES or Protein Sequence) | — |
Identifiers
| PDB | — |
| CAS-ID | — |
| RxCUI | — |
| ChEMBL ID | — |
| ChEBI ID | — |
| PubChem CID | — |
| DrugBank | — |
| UNII ID | — |
Target
No data
Variants
No data
Financial
No data
Trends
No data
Safety
Black-box Warning
No Black-box warning
Adverse Events
Top Adverse Reactions
Mock data
Subscribe for the real data
Subscribe for the real data
6,109 adverse events reported
View more details
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use